Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
July 31, 2015
Primary Completion Date
October 24, 2017
Study Completion Date
October 24, 2017
Conditions
Cancer
Interventions
DRUG
Decitabine and Genistein
intravenous Decitabine with oral genistein
Trial Locations (1)
H3T 1C5
St. Justine's Hospital, Montreal
All Listed Sponsors
lead
St. Justine's Hospital
OTHER
NCT02499861 - Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies | Biotech Hunter | Biotech Hunter